Sunday, December 22, 2024
Facebook Linkedin Twitter
HomeTagsMODULAR

MODULAR

Healthcare

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

PR Newswire -
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...
Information Technology

EPAM Debuts New Cloud-Powered Digital Clinical Trials Platform

PR Newswire -
Clinical trials are a key step to bringing new pharmaceutical drugs to market, but they are also faced with an increasing number of challenges,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us